These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9004110)

  • 1. The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study.
    Verhoeven WM; Tuinier S
    J Intellect Disabil Res; 1996 Dec; 40 ( Pt 6)():502-8. PubMed ID: 9004110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study.
    Ratey J; Sovner R; Parks A; Rogentine K
    J Clin Psychiatry; 1991 Apr; 52(4):159-62. PubMed ID: 2016248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study. The Eltoprazine Aggression Research Group.
    de Koning P; Mak M; de Vries MH; Allsopp LF; Stevens RB; Verbruggen R; Van den Borre R; van Peteghem P; Kohen D; Arumainayagam M
    Int Clin Psychopharmacol; 1994 Sep; 9(3):187-94. PubMed ID: 7814828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buspirone for autistic disorder in a woman with an intellectual disability.
    Brahm NC; Fast GA; Brown RC
    Ann Pharmacother; 2008 Jan; 42(1):131-7. PubMed ID: 18056831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
    Ratey JJ; Sovner R; Mikkelsen E; Chmielinski HE
    J Clin Psychiatry; 1989 Oct; 50(10):382-4. PubMed ID: 2793836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.
    Pruus K; Skrebuhhova-Malmros T; Rudissaar R; Matto V; Allikmets L
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):833-46. PubMed ID: 11220492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects of buspirone on intractable self-injury in adults with mental retardation.
    Ricketts RW; Goza AB; Ellis CR; Singh YN; Chambers S; Singh NN; Cooke JC
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):270-6. PubMed ID: 8150800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats.
    Kanno H; Sekiguchi K; Yamaguchi T; Terawaki K; Yuzurihara M; Kase Y; Ikarashi Y
    J Pharm Pharmacol; 2009 Sep; 61(9):1249-56. PubMed ID: 19703376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of lithium use for institutionalized mentally retarded individuals with behavior disorders.
    Langee HR
    Am J Ment Retard; 1990 Jan; 94(4):448-52. PubMed ID: 2105098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques.
    Fontenot MB; Padgett EE; Dupuy AM; Lynch CR; De Petrillo PB; Higley JD
    Comp Med; 2005 Feb; 55(1):67-74. PubMed ID: 15766212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose buspirone to treat agitation and maladaptive behavior in brain-injured patients: two case reports.
    Ratey JJ; Leveroni CL; Miller AC; Komry V; Gaffar K
    J Clin Psychopharmacol; 1992 Oct; 12(5):362-4. PubMed ID: 1479058
    [No Abstract]   [Full Text] [Related]  

  • 16. An open trial of buspirone in the treatment of attention-deficit disorder.
    Niederhofer H
    Hum Psychopharmacol; 2003 Aug; 18(6):489-92. PubMed ID: 12923830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of buspirone on normal and hypoarousal-driven abnormal aggression in rats.
    Haller J; Horváth Z; Bakos N
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):27-31. PubMed ID: 16893596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief report: Aggressive challenging behaviour in adults with intellectual disability following community resettlement.
    Bhaumik S; Watson JM; Devapriam J; Raju LB; Tin NN; Kiani R; Talbott L; Parker R; Moore L; Majumdar SK; Ganghadaran SK; Dixon K; Das Gupta A; Barrett M; Tyrer F
    J Intellect Disabil Res; 2009 Mar; 53(3):298-302. PubMed ID: 19250390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of buspirone on aggressive and anxiety behavior of male mice with various aggressive experience].
    Bondar' NP; Kudriavtseva NN
    Eksp Klin Farmakol; 2003; 66(4):12-6. PubMed ID: 14558344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of buspirone and fluoxetine in short-term treatment of bulimia nervosa].
    Rajewski A; Rybakowski F
    Psychiatr Pol; 2006; 40(1):75-82. PubMed ID: 16756030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.